Company / Capital Expenditures
Valion Bio, Inc. Capital Expenditures History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$118.0K
FY2024
5-year range
$11.0K / $118.0K
FY2022-FY2024
Trend
+972.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures changed +973% YoY in FY2024, a notable deviation from the 2-year average annual change of +486%.
Based on SEC 10-K filings.
$118,000 in FY2024.
Improved from $11,000 to $118,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, capital expenditures increased 972.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -10.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $118.0K | +972.7% |
| FY2023 | $11.0K | +0.0% |
| FY2022 | $11.0K | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026